STOCK TITAN

Revvity to Present at Upcoming Investor Conferences

Revvity (RVTY) will present at two upcoming investor conferences, with president and chief executive officer Prahlad Singh participating in fireside chats.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:

2026 Jefferies Global Healthcare Conference
Tuesday, November 17, 2026
8:00 a.m. GMT – Prahlad Singh, president and chief executive officer

9th Annual Evercore Healthcare Conference
Wednesday, December 2, 2026
9:10 a.m. ET – Prahlad Singh

Attendees will receive an update on the Company and its strategic priorities during fireside chats.

Live audio webcasts will be available on the Events section of the Company’s website. Replays of the presentations will be posted on the Revvity Investor Relations website after the events and will be available for at least 30 days.

About Revvity

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2025 revenue of $2.9 billion and approximately 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 160 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

Investor Relations
Steve Willoughby
steve.willoughby@revvity.com

Media Relations
Chet Murray
(781) 462-5126
chet.murray@revvity.com

Source: Revvity

Keep reading